Dr. Lepor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
99 N La Cienega Blvd
#203
Beverly Hills, CA 90211Phone+1 310-289-9955Fax+1 310-289-9959
Summary
- Dr. Norman Lepor is a cardiologist in Beverly Hills, CA and is a clinical professor of medicine at the Geffen/UCLA School of Medicine and an attending cardiologists at the Cedars-Sinai Heart Institute. He received his medical degree from Johns Hopkins University School of Medicine and completed his cardiology fellowship at Cedars-Sinai Medical Center. He has been in practice for 32 years. He specializes in interventional cardiology and the treatment of diabetics with cardiovascular disease and is experienced in general cardiology, interventional cardiology, cardiac catheterization, heart failure and complex cardiovascular imaging. He helped pioneer the use of coronary and vascular CT angiography as an important diagnostic tool since 2002. He is an active clinical scientist having participated as a primary investigator in nearly 100 pivotal clinical trials dealing with lipid disorders, heart failure, imaging and diabetes. He is widely published in such journals as the New England Journal of Medicine, JAMA Journal of the American College of Cardiology, Atherosclerosis, Circulation among others. He is also widely sought after as a medical educator and lectures all over the world on a number topics dealing with cardiovascular disease.
Education & Training
- Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1985 - 1988
- Cedars-Sinai Medical CenterResidency, Internal Medicine, 1982 - 1985
- Johns Hopkins University School of MedicineClass of 1982
Certifications & Licensure
- CA State Medical License 1984 - 2026
- MD State Medical License 1982 - 1984
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- CMS Meaningful Use Stage 1 Certification Care360 EHR, MedPlus, 2012
- Join now to see all
Clinical Trials
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
- Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy Start of enrollment: 2012 Jun 01
- A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia Start of enrollment: 2016 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE study.Gurleen Kaur, Robert S Rosenson, Baris Gencer, J Antonio G López, Norman E Lepor
European Heart Journal. 2024-11-20 - 7 citationsDCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.Yehuda Handelsman, John E Anderson, George L Bakris, Christie M Ballantyne, Deepak L Bhatt
Metabolism. 2024-10-01 - 3 citationsThe Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results.Michelle L O'Donoghue, Robert S Rosenson, J Antonio G López, Norman E Lepor, Seth J Baum
Journal of the American College of Cardiology. 2024-08-27
Press Mentions
- Be Wary of Winter Heart AttacksJanuary 23rd, 2023
- This Is the Worst Habit for Heart Health, According to CardiologistsJanuary 18th, 2023
- How to Avoid Cholesterol Spikes During the HolidaysNovember 17th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: